The U.S. Army yesterday issued a revised and updated safety policy for microbiology and biomedical laboratories. The new policy “prescribes the technical safety requirements for the use, handling, transportation, transfer, storage, and disposal of infectious agents and toxins (IAT) rated at biosafety level 2 (BSL–2) and above.” It applies to “all U.S. Army activities and facilities in which IAT are used.”
“Microbiological and biomedical activities are conducted by the U.S. Army in developing measures to identify, detect, diagnose, treat, and protect against IAT,” the 45 page document explains. See “Safety Standards for Microbiological and Biomedical Laboratories” (pdf), U.S. Army Pamphlet 385-69, May 6, 2009.
With targeted policy interventions, we can efficiently and effectively support the U.S. innovation economy through the translation of breakthrough scientific research from the lab to the market.
Crowd forecasting methods offer a systematic approach to quantifying the U.S. intelligence community’s uncertainty about the future and predicting the impact of interventions, allowing decision-makers to strategize effectively and allocate resources by outlining risks and tradeoffs in a legible format.
The energy transition underway in the United States continues to present a unique set of opportunities to put Americans back to work through the deployment of new technologies, infrastructure, energy efficiency, and expansion of the electricity system to meet our carbon goals.
The United States has the only proven and scalable tritium production supply chain, but it is largely reserved for nuclear weapons. Excess tritium production capacity should be leveraged to ensure the success of and U.S. leadership in fusion energy.